Respiratory Virus Infections in Hematopoietic Cell Transplant Recipients
Open Access
- 9 January 2019
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 9, 3294
- https://doi.org/10.3389/fmicb.2018.03294
Abstract
Highly immunocompromised pediatric and adult hematopoietic cell transplant (HCT) recipients frequently experience respiratory infections caused by viruses that are less virulent in immunocompetent individuals. Most of these infections, with the exception of rhinovirus as well as adenovirus and parainfluenza virus in tropical areas, are seasonal variable and occur before and after HCT. Infectious disease management includes sampling of respiratory specimens from nasopharyngeal washes or swabs as well as sputum and tracheal or tracheobronchial lavages. These are subjected to improved diagnostic tools including multiplex PCR assays that are routinely used allowing for expedient detection of all respiratory viruses. Disease progression along with high mortality is frequently associated with respiratory syncytial virus, parainfluenza virus, influenza virus, and metapneumovirus infections. In this review, we discuss clinical findings and the appropriate use of diagnostic measures. Additionally, we also discuss treatment options and suggest new drug formulations that might prove useful in treating respiratory viral infections. Finally, we shed light on the role of the state of immune reconstitution and on the use of immunosuppressive drugs on the outcome of infection.This publication has 183 references indexed in Scilit:
- Human Parainfluenza Virus Infection after Hematopoietic Stem Cell Transplantation: Risk Factors, Management, Mortality, and Changes over TimeTransplantation and Cellular Therapy, 2012
- Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for Diagnosis and Treatment of Human Respiratory Syncytial Virus, Parainfluenza Virus, Metapneumovirus, Rhinovirus, and CoronavirusClinical Infectious Diseases, 2012
- Impact of Corticosteroid Treatment and Antiviral Therapy on Clinical Outcomes in Hematopoietic Cell Transplant Patients Infected with Influenza VirusTransplantation and Cellular Therapy, 2011
- The Microbiome and Butyrate Regulate Energy Metabolism and Autophagy in the Mammalian ColonCell Metabolism, 2011
- Microbiota regulates immune defense against respiratory tract influenza A virus infectionProceedings of the National Academy of Sciences of the United States of America, 2011
- Viral Infections in Immunocompromised PatientsTransplantation and Cellular Therapy, 2011
- Human Bocaviruses Are Highly Diverse, Dispersed, Recombination Prone, and Prevalent in Enteric InfectionsThe Journal of Infectious Diseases, 2010
- Rapid Selection of Oseltamivir‐ and Peramivir‐Resistant Pandemic H1N1 Virus during Therapy in 2 Immunocompromised HostsClinical Infectious Diseases, 2010
- Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global PerspectiveTransplantation and Cellular Therapy, 2009
- Identification of a new human coronavirusNature Medicine, 2004